MINUTO, FRANCESCO
 Distribuzione geografica
Continente #
EU - Europa 18.965
AS - Asia 1.712
NA - Nord America 904
SA - Sud America 119
AF - Africa 23
OC - Oceania 2
Totale 21.725
Nazione #
IT - Italia 18.707
US - Stati Uniti d'America 837
SG - Singapore 761
CN - Cina 424
VN - Vietnam 299
FR - Francia 126
BD - Bangladesh 77
BR - Brasile 74
HK - Hong Kong 50
FI - Finlandia 34
CA - Canada 31
JP - Giappone 25
DE - Germania 23
MX - Messico 21
AR - Argentina 20
GB - Regno Unito 19
CH - Svizzera 16
IQ - Iraq 13
ID - Indonesia 12
EC - Ecuador 10
IE - Irlanda 10
JM - Giamaica 6
SA - Arabia Saudita 6
CL - Cile 5
IN - India 5
NL - Olanda 5
PH - Filippine 5
UA - Ucraina 5
VE - Venezuela 5
ZA - Sudafrica 5
RU - Federazione Russa 4
TH - Thailandia 4
AZ - Azerbaigian 3
JO - Giordania 3
KE - Kenya 3
KR - Corea 3
KZ - Kazakistan 3
SE - Svezia 3
TN - Tunisia 3
UZ - Uzbekistan 3
AU - Australia 2
BY - Bielorussia 2
CO - Colombia 2
DO - Repubblica Dominicana 2
ES - Italia 2
ET - Etiopia 2
MY - Malesia 2
PE - Perù 2
PK - Pakistan 2
PS - Palestinian Territory 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BZ - Belize 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DJ - Gibuti 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
GT - Guatemala 1
HN - Honduras 1
IL - Israele 1
LB - Libano 1
LT - Lituania 1
MK - Macedonia 1
ML - Mali 1
MM - Myanmar 1
NE - Niger 1
NG - Nigeria 1
NI - Nicaragua 1
OM - Oman 1
PL - Polonia 1
RO - Romania 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SZ - Regno dello Swaziland 1
TG - Togo 1
TW - Taiwan 1
VI - Stati Uniti Isole Vergini 1
Totale 21.725
Città #
Genova 12.220
Genoa 3.734
Rapallo 1.625
Vado Ligure 1.056
San Jose 394
Singapore 365
Lauterbourg 123
Ho Chi Minh City 98
Beijing 83
Ashburn 65
Hanoi 58
Hong Kong 49
New York 48
Santa Clara 35
Helsinki 34
Tokyo 24
Frankfurt am Main 22
Bordighera 20
Haiphong 18
Zurich 15
Da Nang 12
Orem 11
Dublin 10
Los Angeles 10
São Paulo 10
Tianjin 10
Mexico City 9
Buffalo 8
San Francisco 8
Chicago 7
Toronto 7
Cardiff 6
City of London 6
Guayaquil 6
Milan 6
Biên Hòa 5
Dallas 5
Rome 5
Thái Bình 5
Baghdad 4
Council Bluffs 4
Montreal 4
Shanghai 4
Amsterdam 3
Atlanta 3
Bắc Ninh 3
Can Tho 3
Denver 3
Guangzhou 3
Huế 3
Hải Dương 3
Joinville 3
Kingston 3
Kyiv 3
London 3
Manchester 3
Nairobi 3
Ninh Bình 3
Riyadh 3
Surabaya 3
Tashkent 3
The Bronx 3
Tulsa 3
Addis Ababa 2
Amman 2
Ancona 2
Baku 2
Bangkok 2
Bellevue 2
Boardman 2
Brooklyn 2
Campinas 2
Cape Town 2
Cleveland 2
Coro 2
Des Moines 2
Gatineau 2
Imus 2
Jakarta 2
Johannesburg 2
Laval 2
Lima 2
Madrid 2
Miami 2
Nha Trang 2
Philadelphia 2
Phoenix 2
Phủ Lý 2
Piscataway 2
Plymouth 2
Queens 2
Reconquista 2
Ribeirão Preto 2
Rio de Janeiro 2
Robion 2
Santiago 2
Seattle 2
Secaucus 2
Stockholm 2
Sydney 2
Totale 20.382
Nome #
Autonomic nervous system and cardiovascular risk assessment during one year of growth hormone (GH) replacement therapy in adults with GH deficiency. 233
Long-term outcome after radioiodine therapy with adjuvant rhTSH treatment: comparison between patients with non-toxic and pre-toxic large multinodular goitre. 230
Acromegaly is associated with increased cancer risk: A survey in Italy 216
SOMATOSTATIN AND DOPAMINE RECEPTOR INTERACTION IN PROSTATE AND LUNG CANCER CELL LINES 212
Effect of environment on growth: auxological and hormonal parameters in African and Italian children 212
Neuroendocrine-immune interactions: the role of cortistatin/somatostatin system 210
Diabetes secondary to neuroendocrine gastroenteropancreatic tumors 210
Pituitary image: pituicytoma. 201
Computed tomography colonography in acromegaly 200
Increasing hirsutism due to a granulosa-cell tumor in a woman with polycystic ovary syndrome: case report and review of the literature. 195
Absence of histological malignancy in a patient cohort with follicular lesions on fine-needle aspiration 194
Evaluation of growth hormone administration in patients with chronic heart failure secondary to coronary artery disease 192
The clinical-molecular interface of somatostatin, dopamine and their receptors in pituitary pathophysiology 191
Indirect evidence of hormone abuse. Proof of doping? 191
Effects of recombinant human growth hormone on muscle protein turnover in malnourished hemodialysis patients 190
Calcitonin assay in wash-out fluid after fine-needle aspiration biopsy in patients with a thyroid nodule and border-line value of the hormone 190
Effects of uremia and inflammation on growth hormone resistance in patients with chronic kidney diseases 187
Rapid pituitary tumor shrinkage with dissociation between antiproliferative and antisecretory effects of a long-acting octreotide in an acromegalic patient 187
A case-controlled study on the quality of life in a cohort of patients with history of differentiated thyroid carcinoma 187
Characterization of the IGF system in 15 patients with Alstrom syndrome. 187
Assessment of the awareness and management of cardiovascular complications of acromegaly in Italy. The COM.E.T.A. (COMorbidities Evaluation and Treatment in Acromegaly) Study 186
Partial visual recovery from radiation-induced optic neuropathy after hyperbaric oxygen therapy in a patient with Cushing disease 184
Balance between somatostatin and D2 receptor expression drives TSH-secreting adenoma response to somatostatin analogs and dopastatins 183
Diagnostic value of the acid-labile subunit in Acromegaly: Evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3 181
Preclinical and clinical experiences with the role of dopamine receptors in the treatment of pituitary adenomas 181
Characterization and sub-cellular localization of SS1R, SS2R, and SS5R in human late-stage prostate cancer cells: effect of mono- and bi-specific somatostatin analogs on cell growth. 181
Effects of the neuropeptide Y on estradiol and progesterone secretion by human granulosa cells in culture 181
Biochemical diagnosis and assessment of disease activity in acromegaly: a two-decade experience. 180
A unique association of clinical "persistent müllerian duct syndrome" and syringoid carcinoma of the perineal-scrotal skin: a consequence of urologic surgery? 178
The pathology of the ulnar nerve in acromegaly. 177
Assessment of disease activity in acromegaly by means of a single blood sample: comparison of the 120th minute postglucose value with spontaneous GH secretion and with the IGF system 176
Effect of the somatostatin analog, octreotide, and of other hormones on the release of the acid-labile subunit of the 150 kDa complex by rat hepatocyte in primary culture. 174
Immunoreactive insulin-like growth factor I (IGF-I) and IGF-I-binding protein content in human thyroid tissue. 170
Insulin-like growth factors (IGF-I and IGF-II) and IGF-binding protein-3 production by fibroblasts of patients with turner's syndrome in culture 169
Effect of the acid-labile subunit on the binding of insulin-like growth factor (IGF)-binding protein-3 to [125I]IGF-I. J.Clin.Endocrinol.Metab. 80 (4):1318-1324, 1995. 167
Circulating nitric oxide in women affected by weight loss amenorrhea during pulsatile gonadotropin-releasing hormone therapy 167
Somatostatin and dopamine receptor expression in lung carcinoma cells and effects of chimeric somatostatin-dopamine molecules on cell proliferation 166
Activity of GH/IGF-I axis in trauma and septic patients during artificial nutrition: different behavior patterns? 165
Pancreatic Islet Cell Tumor Secreting Insulin-Like Growth Factor Type-II in a Dog. 164
Absence of thyrotropin-induced increase in leptin levels in patients with history of differentiated thyroid carcinoma undergoing recombinant human thyrotropin testing 164
Therapeutic Strategies and Clinical Outcome in Papillary Thyroid Microcarcinoma: A Multicenter Observational Study. 164
Paraneoplastic hypoglycemia due to an insulin-like growth factor type-II secreting hepatocellular carcinoma in a dog. 161
Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities 161
Assessment of the awareness and management of sleep apnea syndrome in acromegaly. The COM.E.TA (Comorbidities Evaluation and Treatment in Acromegaly) Italian Study Group 161
Dose-response study of GH effects on circulating IGF-I and IGFBP-3 levels in healthy young men and women 161
Overexpression of stromal cell-derived factor 1 and its receptor CXCR4 induces autocrine/paracrine cell proliferation in human pituitary adenomas 161
Somatostatin receptor scintigraphy in thoracic diseases 160
Evidence for autocrine mitogenic stimulation by somatomedin- C/insulin-like growth factor I on an established human lung cancer cell line 160
Initial staging of lymphoma with octreotide and other receptor imaging agents. 159
Effects of growth hormone on leptin metabolism and energy expenditure in hemodialysis patients with protein-calorie malnutrition 159
Growth hormone secretion in pubertal and adult subjects. 159
Leptin, ghrelin, and adiponectin evaluation in transsexual subjects during hormonal treatments 157
Interrelationships between follicle stimulating hormone and the growth hormone--insulin-like growth factor--IGF-binding proteins axes in human granulosa cells in culture 157
Insulin treatment enhances expression of IGF-I in sural nerves of diabetic patients. 157
Evidence for an increased somatomedin-C/insulin-like growth factor I content in primary human lung tumors 157
Effect of different therapeutic modalities on spontaneous GH secretion in acromegalic patients 156
Pituitary tumor disappearance in a patient with newly diagnosed acromegaly primarily treated with octreotide LAR 155
Immunoreactivity Score Using an Anti-sst2A Receptor Monoclonal Antibody Strongly Predicts the Biochemical Response to Adjuvant Treatment with Somatostatin Analogs in Acromegaly 154
Normal age-dependent values of serum insulin growth factor-I: results from a healthy Italian population 153
STUDY OF BIOASSAYABLE SOMATOMEDIN ON RENAL ARTERY AND VEIN 153
Significant tumour shrinkage after 12 months of Lanreotide Autogel-120 mg treatment given first-line in acromegaly 152
Reduced coronary flow reserve in patients with primary hyperparathyroidism: a study by G-SPECT myocardial perfusion imaging. 152
Partial characterization of somatomedin C-like immunoreactivity secreted by breast cancer cells in vitro. 152
Behaviour of typeII receptors of IGFs in different age and thyroid status in adult rat liver 151
Papillary thyroid cancer in a struma ovarii: a report of a rare case 150
Efficacy of sorafenib and impact on cardiac function in patients with thyroid cancer: a retrospective analysis. 149
Ultrasonography thyroid volume estimation in hyperthyroid patients treated with individual radioiodine dose. 148
Insulin-like growth factor I (IGF I) receptor autophosphorylation and kinase activity. Effect of a human polyclonal antibody (pIgG) 148
Decreased serum somatomedin C concentrations during sleep: temporal relationship to the nocturnal surges of growth hormone and prolactin. 148
Rationale and design of PATRO Adults, a multicentre, noninterventional study of the long-term efficacy and safety of Omnitrope(R) for the treatment of adult patients with growth hormone deficiency 148
Role of dopamine receptors in normal and tumoral pituitary corticotropic cells and adrenal cells 147
P68 Insulin-like growth factor (IGF) binding protein-3 inhibits IGF-II-stimulated IRS-1/PI-3-kinase activity and cell growth in human non-small cell lung cancer (NSCLC) cell lines 147
Trigger Finger, an Early Musculoskeletal Manifestation of Acromegaly 146
Effect of octreotide on circulating IGF-I chromatographic profile: evidence for an inhibitory action on the formation of the 150-kDa ternary complex 146
Treatment of a pituitary metastasis from a neuroendocrine tumour: case report and literature review. 146
Sympathovagal imbalance in acromegalic patients 145
OR2,6 Interrelationship between somatostatin/dopamine pathways and growth factors in non-small lung cancer cells 145
Effects of microinflammation on growth hormone's sensitivity of potassium and amino acid metabolism in patients with chronic renal failure. 144
Cost-of-illness study in acromegalic patients in Italy 142
Effects of alpha-interferon on insulin-like growth factor-I, insulin-like growth factor-II and insulin-like growth factor binding protein-3 secretion by a human lung cancer cell line in vitro. 142
Polycythemia as rare secondary direct manifestation of acromegaly: management and single-centre epidemiological data. 142
Long-term outcome of low-activity radioiodine administration preceded by adjuvant recombinant human TSH pretreatment in elderly subjects with multinodular goiter. 141
Bilateral carcinoma in situ of the testis and cystic fibrosis transmembrane conductance regulator (CFTR) mutation in an azoospermic patient with late-onset 21beta-hydroxylase deficiency. 141
In vivo and in vitro response to octreotide LAR in a TSH-secreting adenoma: characterization of somatostatin receptor expression and role of subtype 5 139
Wireless connections in a hospital ward: the WARD-IN-HAND Project 138
P87 Effect of exenatide, sitagliptin and vildagliptin on IGF-I in diabetic patients 138
Current diagnostic guidelines for biochemical diagnosis of acromegaly. 136
Ultrasound measurement of median and ulnar nerve cross-sectional area in acromegaly. 136
Effect of short-term treatment with low dosages of the proton-pump inhibitor omeprazole on serum chromogranin A levels in man. 135
Short stature associated with high circulating insulin-like growth factor (IGF)-binding protein-1 and low circulating IGF-II: effect of growth hormone therapy 135
Regulation Of Prostate Cancer Cell Proliferation By Somatostatin Receptor Activation 135
Replacement therapy and cardiovascular diseases 134
Growth hormone response to clonidine in anovulatory infertile women resistant to clomiphene citrate stimulation 133
Increased insulin-like growth factor (IGF)-II and IGF/IGF-binding protein ratio in prepubertal constitutionally tall children 133
Ten years of gastroeneteropancreatic neuroendocrine tumors: is reclassification Worth while? 131
Abstracts of the 6th Annual ENETS Conference, Granada, Spain, March 5–7, 2009 131
Institutional experience of PTH evaluation on fine-needle washing after aspiration biopsy to locate hyperfunctioning parathyroid tissue. 130
Immunohistochemical localization and quantitative expression of somatostatin receptors in normal human spleen and thymus: implications for the in vivo visualization during somatostatin receptor scintigraphy. 130
The undescended testis. Prevalence and clinical features 130
Potential indications for somatostatin analogues: immune system and lymphoproliferative disorders 130
Totale 16.320
Categoria #
all - tutte 62.919
article - articoli 58.942
book - libri 0
conference - conferenze 2.760
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.217
Totale 125.838


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202188 0 0 0 0 0 0 0 0 0 0 0 88
2021/20221.863 35 97 168 233 72 128 134 434 89 174 58 241
2022/20231.937 177 143 37 227 310 351 3 130 303 5 226 25
2023/2024782 41 105 12 114 65 128 51 46 46 14 57 103
2024/20252.650 53 183 76 172 389 247 281 435 103 86 277 348
2025/20264.140 535 95 214 318 616 388 747 175 287 352 239 174
Totale 21.774